Now serving 20 states: Arizona, Colorado, Connecticut, Florida, Idaho, Iowa, Kansas, Maryland, Massachusetts, Michigan, Nebraska, New Hampshire, New Mexico, New York, Oregon, Utah, Vermont, Washington, Wisconsin, and Wyoming
The optimal dosage is 1000 to 2000 mg per day, depending on activity level
Scientific interest has focused on how combined receptor activity may affect appetite signaling, energy balance, glucose regulation, insulin-related pathways, and lipid metabolism
Infantile neuroaxonal dystrophy (INAD, OMIM #256600, also known as neurodegeneration with brain iron accumulation 2A [NBIA2A]) is an intractable neurometabolic infantile disease associated with mutations in the PLA2G6 gene 1
Retatrutide produces larger improvements in cardiovascular risk factors than approved medications
GSTK and MAPEG are identified as mitochondrial and microsomal GST, respectively, and the others are as cytosolic GST 14,15